3 ms·
No offense, but I do this stuff for a living. Yes, not all insurance companies in the US approve the day after. But some do (I’ve personally witnessed it). H
by refurb 7y ago
No offense, but I do this stuff for a living.
Yes, not all insurance companies in the US approve the day after. But some do (I’ve personally witnessed it). How else would newly launched drugs have sales in the first quarter? People sure as hell aren’t paying cash.
Since it’s before a policy is formally written, it’s often a manual approval based on medical necessity. The issue with PA denials is separate from actual reimbursement, Germany has PA requirements too (as they should, why pay for a new drug if an old drug works just fine). I never said it was easy, I just stayed they are paid for quite quickly.
A drug I recently launch was approved by the EMA last year, it’s still not available in many EU countries because reimbursement hasn’t yet been approved.
And yes, the drugs are expensive, but at least with orphan drugs, they still cost hundreds of thousands in the EU. The price window for orphan drugs is quite narrow between the US and EU.